CellaVision AB (publ) (OTCMKTS:CLVSF) Short Interest Down 6.3% in March

CellaVision AB (publ) (OTCMKTS:CLVSF) was the recipient of a significant decline in short interest during the month of March. As of March 31st, there was short interest totalling 1,500 shares, a decline of 6.3% from the March 15th total of 1,600 shares. Based on an average daily trading volume, of 100 shares, the days-to-cover ratio is currently 15.0 days.

CellaVision AB (publ) Price Performance

CellaVision AB (publ) stock remained flat at $20.36 during midday trading on Tuesday. CellaVision AB has a 12-month low of $20.36 and a 12-month high of $23.75. The stock has a 50 day moving average of $20.39 and a 200-day moving average of $18.01.

About CellaVision AB (publ)

CellaVision AB (publ) develops and sells digital solutions for blood and body fluids analysis in Sweden and internationally. The company provides CellaVision DM1200 and CellaVision DM9600, which automatically capture digital images of cells from blood smears and body fluid preparations; CellaVision DC-1, an analyzer to enable low-volume hematology labs to implement CellaVisions digital methodology for performing blood cell; and DIFF-Line that automates and digitizes the process of analyzing peripheral blood smears.